Fluzone QIV HD is under clinical development by Sanofi and currently in Phase II for Unspecified Influenza Virus Infections.

The announcement follows just days after the US Centres for Disease Control confirmed its first death from the zoonotic ...

mRNA-1010 also triggered higher HAI titres against A/H1N1, A/H3N2, B/Victoria, as well as comparable titres to B/Yamagata, in a second phase 1/2 trial comparing it to Sanofi's Fluzone HD vaccine.

Discuss with your doctor, but here’s what is recommended: a high-dose flu shot (Fluad, Flublok, or Fluzone High-Dose), the updated COVID-19 shot, the respiratory syncytial virus (RSV ...

The trial looked at the efficacy of mRNA-1083 in one group of adults 65 years and older who received Moderna’s jab or Sanofi’s high-dose flu vaccine Fluzone HD, co-administered with Moderna ...

Merck shares trade at a significant discount to peers. The company faces challenges, but there are reasons to be bullish.